CHPF anticorps (N-Term)

N° du produit ABIN635153

L’anticorps Lapin Polyclonal anti-CHPF a été validé pour WB. Il convient pour détecter CHPF dans des échantillons de Humain.

Aperçu rapide pour CHPF anticorps (N-Term) (ABIN635153)

Antigène: CHPF (Chondroitin Polymerizing Factor (CHPF))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHPF est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-CHPF anticorps

Épitope: N-Term

Specificité: CHSY2 antibody was raised against the N terminal Of Chsy-2

Purification: Affinity purified

Immunogène: CHSY2 antibody was raised using the N terminal Of Chsy-2 corresponding to a region with amino acids PPLQQRRRGREPEGATGLPGAPAAEGEPEEEDGGAAGQRRDGRPGSSHNG

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

CHSY2 Blocking Peptide, (ABIN5612880), is also available for use as a blocking control in assays to test for specificity of this CHSY2 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CHSY-2 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur CHPF

Antigène: CHPF (Chondroitin Polymerizing Factor (CHPF))

Autre désignation: CHSY2

Sujet: CHSY-2 has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. CHSY-2 transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Specific activity of CHSY-2 is much reduced compared to CHSY1.CSS3 is a glycosyltransferase that has both glucuronyltransferase and N-acetylgalactosaminyltransferase activities.

Poids moléculaire: 100 kDa (MW of target protein)

Pathways: Glycosaminoglycan Metabolic Process, SARS-CoV-2 Protein Interactome